Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
AUTOR(ES)
Jeha, Sima
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2744276Documentos Relacionados
- What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
- Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
- Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies